Pierre Montanaro - Devonian Health CEO Pres

GSD Stock  CAD 0.24  0.02  9.09%   

Insider

Pierre Montanaro is CEO Pres of Devonian Health Group
Address 360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1
Phone514 248 7509
Webhttps://groupedevonian.com

Devonian Health Management Efficiency

The company has return on total asset (ROA) of (0.0129) % which means that it has lost $0.0129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0607) %, meaning that it generated substantial loss on money invested by shareholders. Devonian Health's management efficiency ratios could be used to measure how well Devonian Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Devonian Health's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to climb to about 7.2 M in 2025, whereas Other Current Assets are likely to drop 4,731 in 2025.
Devonian Health Group has accumulated 2.08 M in total debt with debt to equity ratio (D/E) of 43.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Devonian Health Group has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Devonian Health until it has trouble settling it off, either with new capital or with free cash flow. So, Devonian Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Devonian Health Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Devonian to invest in growth at high rates of return. When we think about Devonian Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Martin ViechaTesla Inc CDR
N/A
Sergey BrinAlphabet Inc CDR
51
Mark BrittoPayPal Holdings CDR
59
Gabrielle JDPayPal Holdings CDR
45
Satya NadellaMicrosoft Corp CDR
58
Sundar PichaiAlphabet Inc CDR
52
Jeffrey KarbowskiPayPal Holdings CDR
46
Zachary KirkhornTesla Inc CDR
39
Alan PrescottTesla Inc CDR
45
Larry PageAlphabet Inc CDR
51
Sripada ShivanandaPayPal Holdings CDR
51
Daniel SchulmanPayPal Holdings CDR
66
Frank ShawMicrosoft Corp CDR
N/A
Kent WalkerAlphabet Inc CDR
64
Jonathan AuerbachPayPal Holdings CDR
61
Franz HolzhausenTesla Inc CDR
N/A
Keith EsqMicrosoft Corp CDR
N/A
Christopher CaposselaMicrosoft Corp CDR
54
Dave ArnoldTesla Inc CDR
N/A
Alfonso VillanuevaPayPal Holdings CDR
N/A
Fiona CicconiAlphabet Inc CDR
59
Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs. The company was incorporated in 2013 and is headquartered in Qubec, Canada. DEVONIAN HEALTH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. Devonian Health Group (GSD) is traded on TSX Venture Exchange in Canada and employs 6 people. Devonian Health is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Devonian Health Group Leadership Team

Elected by the shareholders, the Devonian Health's board of directors comprises two types of representatives: Devonian Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Devonian. The board's role is to monitor Devonian Health's management team and ensure that shareholders' interests are well served. Devonian Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Devonian Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pierre Montanaro, CEO Pres
Andre Boulet, Chief Director
Viktoria Krasteva, Chief Officer
MSc CFA, VP Director

Devonian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Devonian Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Devonian Stock Analysis

When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.